tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Germany Market

Infant Bacterial Therapeutics AB (9IB) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

9IB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Infant
Bacterial Therapeutics AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

9IB Stock 12 Month Forecast

There Are No Analyst Ratings for DE:9IB In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

9IB Financial Forecast

9IB Earnings Forecast

Next quarter’s earnings estimate for 9IB is -€0.13 with a range of -€0.13 to -€0.13. The previous quarter’s EPS was -€0.13. 9IB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 9IB has Performed in-line its overall industry.
Next quarter’s earnings estimate for 9IB is -€0.13 with a range of -€0.13 to -€0.13. The previous quarter’s EPS was -€0.13. 9IB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 9IB has Performed in-line its overall industry.
No data currently available

9IB Sales Forecast

Next quarter’s sales forecast for 9IB is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 9IB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 9IB has Performed in-line its overall industry.
Next quarter’s sales forecast for 9IB is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 9IB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 9IB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - Google Analyst forecast on DE:9IB
TipRanks - Google
TipRanks - Google
€4.51
Hold
0.72%
Upside
Initiated
01/15/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:9IB
TipRanks - OpenAI
TipRanks - OpenAI
€4.51
Hold
0.72%
Upside
Reiterated
12/30/25
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - Google Analyst forecast on DE:9IB
TipRanks - Google
TipRanks - Google
€4.51
Hold
0.72%
Upside
Initiated
01/15/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:9IB
TipRanks - OpenAI
TipRanks - OpenAI
€4.51
Hold
0.72%
Upside
Reiterated
12/30/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

9IB Analyst Recommendation Trends

Rating
Apr 25
Dec 25
Jan 26
Strong Buy
0
0
0
Buy
0
0
0
Hold
1
2
3
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
3
In the current month, 9IB has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 9IB average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

9IB Stock Forecast FAQ

What is DE:9IB’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:9IB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:9IB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Infant Bacterial Therapeutics AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Infant Bacterial Therapeutics AB’s share price target?
      Currently, no data Available
      What do analysts say about Infant Bacterial Therapeutics AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Infant Bacterial Therapeutics AB?
      To buy shares of DE:9IB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.